EcoDrugPlus

Bcl2 Apoptosis Regulator

Ensembl ID : ENSDNOG00000046967
Gene Symbol: BCL2
4 Cross references
228 Possible Orthologues:

Bcl2 Like 1

Ensembl ID : ENSDNOG00000038284
Gene Symbol: BCL2L1
2 Cross references
289 Possible Orthologues:

Bcl2 Like 2

Ensembl ID : ENSDNOG00000047570
Gene Symbol: BCL2L2
2 Cross references
64 Possible Orthologues:

Bcl2 Related Protein A1

Ensembl ID : ENSDNOG00000039285
Gene Symbol: BCL2A1
4 Cross references
133 Possible Orthologues:

Bcr Activator Of Rhogef And Gtpase

Ensembl ID : ENSDNOG00000002594
Gene Symbol: BCR
2 Cross references
288 Possible Orthologues:

Bruton Tyrosine Kinase

Ensembl ID : ENSDNOG00000015948
Gene Symbol: BTK
2 Cross references
207 Possible Orthologues:

C-C Chemokine Receptor Type 5

Ensembl ID : ENSDNOG00000045226
Gene Symbol: LOC101434490
3 Cross references
150 Possible Orthologues:

C-C Motif Chemokine Receptor 1

Ensembl ID : ENSDNOG00000038727
Gene Symbol: CCR1
2 Cross references
158 Possible Orthologues:

C-C Motif Chemokine Receptor 2

Ensembl ID : ENSDNOG00000024612
Gene Symbol: CCR2
3 Cross references
150 Possible Orthologues:

C-C Motif Chemokine Receptor 4

Ensembl ID : ENSDNOG00000016020
Gene Symbol: CCR4
4 Cross references
113 Possible Orthologues:

C-C Motif Chemokine Receptor 9

Ensembl ID : ENSDNOG00000011212
Gene Symbol: CCR9
4 Cross references
265 Possible Orthologues:

C-X-C Motif Chemokine Ligand 8

Ensembl ID : ENSDNOG00000032213
Gene Symbol: CXCL8
4 Cross references
179 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).